跳至主要内容
临床试验/JPRN-UMIN000012874
JPRN-UMIN000012874招募中未知

Prospective multicenter clinical study on outcome measures for HTLV-1-associated myelopathy (HAM) - HAM-OM

St. Marianna University0 个研究点目标入组 150 人开始时间: 2014年1月16日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with spinal cord compression lesion complications such as from cervical spine disease,intervertebral disc herniation, or yellow ligament ossification that affect gait assessment 2. Patients with knee or hip osteoarthritis, rheumatoid arthritis, or another musculoskeletal disease that affects gait assessment 3. Patients with Parkinsons disease or the aftereffects of stroke, cerebral hemorrhage, subarachnoid hemorrhage or other neurological disturbance affecting gait assessment 4. Serious complications that affect gait assessment (heart failure, respiratory dysfunction, renal failure, liver failure, etc.) 5. Patients with mental disorders such as dementia or neuropsychiatric diseases that affect ability to answer interview questions 6. Patients with any disease other than HAM for which they might be prescribed steroids (excluding topic medicines), interferon, or anti-cancer drugs 7. Patients with both severe anemia (hemoglobin less than 9.0 g/dl) and intracranial hypotension syndrome from whom it is deemed unwise with regard to the subjects safety to collect blood or CSF samples 8. Patients who have been deemed unfit for the study by a study investigator or physician.

研究者

发起方
St. Marianna University

相似试验